GuangYuYuan Chinese Herbal Medicine Co Ltd Market Cap ($911.82 Million)
Market Cap & Net Worth: GuangYuYuan Chinese Herbal Medicine Co Ltd (600771)
GuangYuYuan Chinese Herbal Medicine Co Ltd market cap. GuangYuYuan Chinese Herbal Medicine Co Ltd (SHG:600771) has a market capitalization of $911.82 Million (CN¥6.23 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #8979 globally and #2160 in its home market, demonstrating a 4.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GuangYuYuan Chinese Herbal Medicine Co Ltd's stock price CN¥12.73 by its total outstanding shares 489491141 (489.49 Million). Also see 600771 cash flow metrics for how efficiently the company converts equity into cash flow.
GuangYuYuan Chinese Herbal Medicine Co Ltd Market Cap History (2015–2026)
GuangYuYuan Chinese Herbal Medicine Co Ltd market cap history from 2015 to 2026. Data shows change from $1.64 Billion to $911.82 Million (-3.84% CAGR). Check 600771 stock price and chart for real-time trading data and today's change.
GuangYuYuan Chinese Herbal Medicine Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GuangYuYuan Chinese Herbal Medicine Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 600771 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.94x
GuangYuYuan Chinese Herbal Medicine Co Ltd's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
20.43x
GuangYuYuan Chinese Herbal Medicine Co Ltd's market cap is 20.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.71 Billion | $936.99 Million | $122.81 Million | 1.83x | 13.93x |
| 2017 | $2.09 Billion | $1.17 Billion | $236.80 Million | 1.79x | 8.81x |
| 2018 | $1.48 Billion | $1.62 Billion | $374.11 Million | 0.91x | 3.95x |
| 2019 | $1.21 Billion | $1.22 Billion | $130.07 Million | 1.00x | 9.34x |
| 2020 | $1.07 Billion | $1.11 Billion | $32.00 Million | 0.96x | 33.42x |
| 2021 | $3.08 Billion | $854.22 Million | -$316.24 Million | 3.61x | N/A |
| 2022 | $1.99 Billion | $1.13 Billion | -$250.02 Million | 1.76x | N/A |
| 2023 | $1.93 Billion | $1.28 Billion | $90.08 Million | 1.51x | 21.46x |
| 2024 | $1.35 Billion | $1.22 Billion | $74.45 Million | 1.11x | 18.14x |
| 2025 | $1.29 Billion | $1.37 Billion | $63.04 Million | 0.94x | 20.43x |
Competitor Companies of 600771 by Market Capitalization
Companies near GuangYuYuan Chinese Herbal Medicine Co Ltd in the global market cap rankings as of November 8, 2026. Also see 600771 total asset value for a full breakdown of the balance sheet.
Key companies related to GuangYuYuan Chinese Herbal Medicine Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #19 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #28 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #42 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1354.00 |
| #19 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #28 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $276.22 |
| #42 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $291.31 |
Market Capitalization of GuangYuYuan Chinese Herbal Medicine Co Ltd (2015–2026)
Market capitalization of GuangYuYuan Chinese Herbal Medicine Co Ltd from 2015 to today. Between 2015 and today, GuangYuYuan Chinese Herbal Medicine Co Ltd's market cap moved from $1.64 Billion to $ 911.82 Million, with a yearly change of -3.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥911.82 Million | -29.20% |
| 2025 | CN¥1.29 Billion | -4.67% |
| 2024 | CN¥1.35 Billion | -30.12% |
| 2023 | CN¥1.93 Billion | -2.98% |
| 2022 | CN¥1.99 Billion | -35.39% |
| 2021 | CN¥3.08 Billion | +188.41% |
| 2020 | CN¥1.07 Billion | -11.97% |
| 2019 | CN¥1.21 Billion | -17.76% |
| 2018 | CN¥1.48 Billion | -29.21% |
| 2017 | CN¥2.09 Billion | +21.95% |
| 2016 | CN¥1.71 Billion | +4.57% |
| 2015 | CN¥1.64 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of GuangYuYuan Chinese Herbal Medicine Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $911.82 Million USD |
| MoneyControl | $911.82 Million USD |
| MarketWatch | $911.82 Million USD |
| marketcap.company | $911.82 Million USD |
| Reuters | $911.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GuangYuYuan Chinese Herbal Medicine Co Ltd
GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional Chinese medicine, fine Chinese medicine, and health wine. It provides its products in the form of pills, powders, tablets, hard capsules, granules, compound preparations, and medicated eight dosage forms. The company was formerly known as Topsun Science And Technology Co… Read more